ANDA 76041, held by Sun Pharm Inds Ltd. Isotretinoin.
As of Nov 16, 2026, ANDA 76041 (Sotret), held by Sun Pharm Inds Ltd, was first approved by FDA on Dec 24, 2002, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 24, 2002 | Original application | Approved |
| Sotret10MG · capsule;oral | Isotretinoin | Discontinued |
| Sotret20MG · capsule;oral | Isotretinoin | Discontinued |
| Sotret40MG · capsule;oral | Isotretinoin | Discontinued |
| Apr 12, 2012 | Supplement 18REMS | Approved | None posted |
| Oct 22, 2010 | Supplement 8REMS | Approved | None posted |
| Mar 25, 2010 | Supplement 7Labeling | Approved | None posted |
| Aug 20, 2009 | Supplement 6Labeling | Approved | None posted |
| Nov 2, 2007 | Supplement 5Labeling | Approved | None posted |
| Feb 6, 2007 | Supplement 3Labeling | Approved | None posted |
| Feb 6, 2007 | Supplement 4Labeling | Approved | None posted |
| Aug 12, 2005 | Supplement 2Labeling | Approved | None posted |
| May 28, 2003 | Supplement 1Labeling | Approved | None posted |
| Dec 24, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters